Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine.
Martinez
C E
CE
LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans 70112-2234, USA.
Zhang
D
D
Conway
M D
MD
Peyman
G A
GA
D000284:Administration, Oral; D000293:Adolescent; D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D007267:Injections; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis / Q000188:drug therapy* / Q000469:parasitology; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use*; D014122:Toxoplasma / Q000276:immunology; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000188:drug therapy* / Q000469:parasitology; D014822:Vitreous Body
D000913:Antibodies, Protozoan; D013411:Sulfadiazine; D002981:Clindamycin; D003907:Dexamethasone